Focusing on Clinically Interpretable Features: Selective Attention Regularization for Liver Biopsy Image Classification

[1]  K. Cusi,et al.  Corrigendum:The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.

[2]  Aijaz Ahmed,et al.  Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. , 2015, Gastroenterology.

[3]  Anne L. Martel,et al.  Deep neural network models for computational histopathology: A survey , 2019, Medical Image Anal..

[4]  Tong Liu,et al.  Segmentation of histological images and fibrosis identification with a convolutional neural network , 2018, Comput. Biol. Medicine.

[5]  Wei-Shi Zheng,et al.  Deep kNN for Medical Image Classification , 2020, MICCAI.

[6]  A. Chauhan,et al.  Medical liver biopsy: background, indications, procedure and histopathology , 2019, Frontline Gastroenterology.

[7]  Joel Z Stengel,et al.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. , 2011, Gastroenterology.

[8]  Elizabeth M. Brunt,et al.  Pathology of nonalcoholic fatty liver disease , 2010, Nature Reviews Gastroenterology &Hepatology.

[9]  G. Birk,et al.  Deep learning enables pathologist-like scoring of NASH models , 2019, Scientific Reports.

[10]  Yoshihisa Takahashi,et al.  Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. , 2014, World journal of gastroenterology.

[11]  R. Rector,et al.  Nonalcoholic fatty liver disease and mitochondrial dysfunction. , 2008, World journal of gastroenterology.

[12]  F. Tacke,et al.  Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis , 2019, Hepatology.

[13]  A. Tzallas,et al.  High-Throughput, Machine Learning–Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[14]  Yongxiang Huang,et al.  CELNet: Evidence Localization for Pathology Images using Weakly Supervised Learning , 2019, MICCAI.

[15]  Nikos Paragios,et al.  Weakly supervised multiple instance learning histopathological tumor segmentation , 2020, MICCAI.

[16]  Ruimao Zhang,et al.  UXNet: Searching Multi-level Feature Aggregation for 3D Medical Image Segmentation , 2020, MICCAI.

[17]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.